These results suggest that, unlike FRA1 in breast cancers without metastasis, FRA1 in most breast cancers with metastasis is likely activated and that the activation of FRA1 is, at least, partially, induced by GATA3 deficiency. Here, FOSL1 is linked to breast cancer.